Grant Young, APRN
Nurse Practitioner · Oklahoma City, OKNPI 1629791777
Payments from drug & device makers
What this record shows
This record is dominated by grants: $10,000 of the $15,094 with a category attached, or 66.3%. Medtronic accounts for 67.7% of it on its own, with 21 other manufacturers making up the rest. 2025 is the largest year on record at $11,294, more than ten times the $13 reported in 2022. Among nurse practitioner clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 62 payments — averaging $243.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$10K
- Cordis US CORP.$2K
- Inari Medical, Inc.$383
- Abbott$333
- Boston Scientific$311
- Nalu Medical, Inc.$300
- plus $1K from 16 others
What the payments were for
- Grants$10,00066%
- Travel & lodging$1,59611%
- Food & beverage$3,49823%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 5 | $10,214 |
| Cordis US CORP. | 8 | $2,181 |
| Inari Medical, Inc. | 3 | $383 |
| Abbott | 3 | $333 |
| Boston Scientific | 5 | $311 |
| Nalu Medical, Inc. | 3 | $300 |
| Silk Road Medical, Inc. | 3 | $224 |
| Novo Nordisk | 4 | $181 |
| Nevro Corp. | 2 | $180 |
| Endologix LLC | 2 | $173 |
| E.r. Squibb & Sons, L.L.C. | 9 | $147 |
| Bolton Medical Inc | 1 | $140 |
| Baxter Healthcare | 1 | $58 |
| Johnson & Johnson | 2 | $46 |
| Kerecis Limited | 2 | $45 |
| Veryan Medical Incorporated | 2 | $35 |
| Stryker | 1 | $30 |
| Actelion Pharmaceuticals US, Inc. | 1 | $29 |
| Merck | 2 | $27 |
| Cvrx, Inc. | 1 | $24 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Angiodynamics, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACTIVA PC$10,000
- ANGIOGUARD$1,054
- PRECISE PRO RX$991
- ENROUTE Transcarotid Neuroprotection System$502
- FLOWTRIEVER CATHETER, S$370
- CT THROMBECTOMY SYSTEM KIT$370
- Nalu Neurostimulation System$292
- ENDURANT IIS$158
- ENDOCROSS Device$149
- Torus Stent Graft System$149
- CARDIOMEMS$144
- TREO ABDOMINAL STENT-GRAFT SYSTEM$140
- Senza$134
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$120
- ENROUTE Transcarotid Stent$120
- Ozempic$117
How this compares
$15,094 in reported general payments places this provider in the 95th percentile of 824 nurse practitioner providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 18 | $26,523 |
| EliquisApixaban | 17 | $20,426 |
| Gabapentin | 32 | $674 |
| Cilostazol | 23 | $575 |
| ClopidogrelClopidogrel Bisulfate | 29 | $276 |
| Ciprofloxacin Hcl | 21 | $236 |
| Doxycycline Hyclate | 16 | $212 |
| Potassium Chloride | 14 | $82 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $46 | $26,52318 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 824 nurse practitioner providers in Oklahoma.
Other nurse practitioner in Oklahoma City
- Sara GoreOklahoma City$52K
- Russell RoomsOklahoma City$24K
- Janelle WagnerOklahoma City$13K
- Stefanie RollinsOklahoma City$13K
- Lacey CampbellOklahoma City$13K
- Stacey Waggoner FisherOklahoma City$9K
- Karie StewartOklahoma City$9K
- Lori CraigOklahoma City$8K
- Jennifer LewisOklahoma City$6K
- Theresa BachOklahoma City$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.